Lucis Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 5.10 M
- Paid Up Capital ₹ 5.02 M
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.85 M
- Revenue Growth -28.46%
- Profit Growth 1.66%
- Ebitda 140.73%
- Net Worth 3.07%
- Total Assets -3.35%
About Lucis Pharmaceutical
Lucis Pharmaceutical Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 November 2004 and has a history of 20 years and three months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.10 M and a paid-up capital of Rs 5.02 M.
The company currently has active open charges totaling ₹1.85 M.
Mukhtar Alam, Salik Mukhtar, and Shaheena Mukhtar serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239WB2004PTC100505
- Company No.
100505
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Lucis Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukhtar Alam  | Director | 16-Nov-2004 | Current |
| Salik Mukhtar | Director | 10-Dec-2018 | Current |
| Shaheena Mukhtar | Director | 16-Nov-2004 | Current |
Financial Performance of Lucis Pharmaceutical.
Lucis Pharmaceutical Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 28.46% decrease. The company also saw a slight improvement in profitability, with a 1.66% increase in profit. The company's net worth moved up by a moderate rise of 3.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lucis Pharmaceutical?
In 2021, Lucis Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Idyllic Retreats Private LimitedMukhtar Alam, Salik Mukhtar and 1 more are mutual person
- Lucis Laboratories Private Limited
Mukhtar Alam, Salik Mukhtar and 1 more are mutual person
- Excel Medpharma Private Limited
Mukhtar Alam, Salik Mukhtar and 1 more are mutual person
Charges (Loans)
₹1.85 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.12 Cr
- Vijaya Bank : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 May 2023 | Hdfc Bank Limited | ₹1.20 M | Open |
| 22 Oct 2014 | Vijaya Bank | ₹0.65 M | Open |
How Many Employees Work at Lucis Pharmaceutical?
Unlock and access historical data on people associated with Lucis Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lucis Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucis Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.